As market shifts, Atlas Venture closes a $250 million fund to support its breakaway biotech bets

Atlas Venture, the Cambridge, Mass.-based early-stage, biotech-focused venture firm, has for the first time raised an opportunity fund designed to help it support its most promising, maturing portfolio companies. The…

Continue ReadingAs market shifts, Atlas Venture closes a $250 million fund to support its breakaway biotech bets